SUBSCRIBE
SUBSCRIBE
News   Policy

Novartis AG Officials Hid Bone Drugs’ Risks, Lawyer Tells Jurors

November 2, 2010 | 
1 min read
Bloomberg -- Novartis AG officials downplayed risks that the drugmaker’s bone-strengthening medicines Aredia and Zometa could destroy patients’ jaws, a lawyer for a woman suing the company told a North Carolina jury.
Legal Europe
Novartis
MORE ON THIS TOPIC
Government
RFK Jr. Firm on HHS Cuts, Wobbles on Measles Vaccine
May 15, 2025
 · 
2 min read
 · 
Tristan Manalac
Pictured: Sign of U.S. Department of Health & Huma
Drug pricing
CMS Prepares for Third Cycle of Drug Negotiations as Trump Intensifies Push To Lower Prices
May 13, 2025
 · 
3 min read
 · 
Tristan Manalac
red figurine of a man stands aside from the crowd of people. Asociality, sociopathy. Rejected from society, lonely. Development of leadership and social qualities. Infected, fear and misunderstanding.
Pharmacy benefit managers
Trump’s Most Favored Nation Policy Sparks PBM Selloff
May 13, 2025
 · 
2 min read
 · 
Tristan Manalac
3D Isometric Flat Vector Illustration of Expensive Unaffordable Drugs, Health Care Costs
Drug pricing
Trump’s Drug Pricing Order ‘More Bark Than Bite’
May 12, 2025
 · 
5 min read
 · 
Annalee Armstrong